Alhemo

concizumab-mtci

Approval

ApplicationBLA 761315
Approval dateDec 20, 2024
Approval year2024
SponsorNovo Nordisk INC

FDA-approved use

For routine prophylaxis to prevent bleeding episodes in hemophilia A and B

Approval package

Query with Claude

The fda-analyst skill answers natural-language questions about this approval by fetching the relevant FDA review PDFs at query time.

git clone https://github.com/cbetz/trove
cp -r trove/skills/fda-analyst ~/.claude/skills/

Example prompts for Alhemo: